Detection of the BCR-ABL gene by interphase fluorescence in situ hybridization (iFISH) in chronic myelogenous leukemia patients after hemopoietic stem cell transplantation: The feasibility of iFISH monitoring of therapeutic response in peripheral blood

International Journal of Hematology

Volumn 76, Issue 2, 2002, Pages 180-185

  You, Kyoung Lee ^a   Dong, Wha Lee ^a   Yoo, Li Kim ^b   Lee, Seok ^b   Chang, Ki Min ^b   Kim, Yoo Jin ^b   Oh, Il Hoan ^b   Kim, Tai Gyu ^b   Chun, Choo Kim ^b   Kim, Dong Wook ^b,c  

^a Soonchunhyang University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

BCR ABL; Chronic myelogenous leukemia; Hemopoietic stem cell transplantation; Interphase FISH

Indexed keywords

BCR ABL PROTEIN; DNA;

ARTICLE; BLOOD; BONE MARROW; CHRONIC MYELOID LEUKEMIA; CORRELATION ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INTERPHASE; LABORATORY DIAGNOSIS; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; BLOOD CELL; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; GENE TRANSLOCATION; GENETICS; MALE; METHODOLOGY; MINIMAL RESIDUAL DISEASE; PATHOLOGY;

BLOOD CELLS; BONE MARROW; CASE-CONTROL STUDIES; DNA, NEOPLASM; FALSE POSITIVE REACTIONS; FEMALE; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; MALE; NEOPLASM, RESIDUAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 0842271657     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982582     Document Type: Article

References (32)

1. Nowell PC, Hungerford DA. A minute chromosome in human chronic myelocytic leukemia. Science. 1960;132:1497-1501.
2. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243:290-293.
3. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell. 1984;36:93-99.
4. Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature. 1985;315:550-554.
5. Arnoldus EP, Wiegant J, Noordermeer IA, et al. Detection of the Philadelphia chromosome in interphase nuclei. Cytogenet Cell Genet. 1990;54:108-111.
6. Tkachuk DC, Westbrook A, Andreeff M, et al. Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization. Science. 1990;250:559-562.
7. Dewald GW, Schad CR, Christensen ER, et al. The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variants Ph chromosomes in CML and ALL. Cancer Genet Cytogenet. 1993;71:7-14.
8. Bentz M, Cabot G, Moos M, et al. Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood. 1994;83:1922-1928.
9. Froncillo MC, Maffei L, Cantonetti M, et al. FISH analysis for CML monitoring? Ann Hematol. 1996;73:113-119.
10. Morgan GJ, Hughes T, Janssen JW, et al. Polymerase chain reaction for detection of residual leukemia. Lancet. 1989;1:928-929.
11. Sklar J. Polymerase chain reaction: the molecular microscope of residual disease. J Clin Oncol. 1991;9:1521-1524.
12. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
13. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature. 1989;339:237-238.
14. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
15. Lukasova E, Kozubek S, Kozubek M, et al. Localisation and distance between ABL and BCR genes in interphase nuclei of bone marrow cells of control donors and patients with chronic myeloid leukaemia. Hum Genet. 1997;100:525-535.
16. Clarkson B, Strife A. Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment. Leukemia. 1993;7:1683-1721.
17. Morley A. Quantifying leukemia. N Engl J Med. 1998;339:627-629.
18. Biernaux C, Loos M, Sels A, Huez G, Stryckmans P. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood. 1995;86:3118-3122.
19. Bose S, Deininger M, Gora-Tybor J, Goldman JM, Melo JV. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood. 1998;92:3362-3367.
20. Faderl S, Talpaz M, Kantarjian HM, Estrov Z. Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making? Blood. 1999;93:2755-2759.
21. Garcia-Isidoro M, Tabernero MD, Garcia JL, et al. Detection of the Mbcr/abl translocation in chronic myeloid leukemia by fluorescence in situ hybridization: comparison with conventional cytogenetics and implications for minimal residual disease detection Hum Pathol. 1997;28:154-159.
22. Muhlmann J, Thaler J, Hilbe W, et al. Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: a new strategy for remission assessment. Genes Chromosomes Cancer. 1998;21:90-100.
23. Yanagi M, Shinjo K, Takeshita A, et al. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells. Leukemia. 1999;13:542-552.
24. Dewald GW, Wyatt WA, Juneau AL, et al. Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. Blood. 1998;91:3357-3365.
25. Sinclair PB, Green AR, Grace C, Nacheva EP. Improved sensitivity of BCR-ABL detection: a triple-probe three-color fluorescence in situ hybridizaton system. Blood. 1997;90:1395-1402.
26. Buno I, Wyatt WA, Zinsmeister AR, Dietz-Band J, Silver RT, Dewald GW. A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia. Blood. 1998;92:2315-2321.
27. Dewald GW, Wyatt WA, Silver RT. Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy. Leuk Lymphoma. 1999;34:481-491.
28. Mohr B, Bornhauser M, Platzbecker U, et al. Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals. Cancer Genet Cytogenet. 2001;27:111-117.
29. Mensink E, van de Locht A, Schattenberg A, et al. Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR. Br J Haematol. 1998;102:768-774.
30. Eder M, Battmer K, Kafert S, Stucki A, Ganser A, Hertenstein B. Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation. Leukemia. 1999;13:1383-1389.
31. Chomel JC, Brizard F, Veinstein A, et al. Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation. Blood. 2000;95:404-408.
32. Le Gouill S, Talmant P, Milpied N, et al. Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia. J Clin Oncol. 2000;18:1533-1538.